BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27731393)

  • 1. Hydroxysafflor yellow A alleviates myocardial ischemia/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling.
    Han D; Wei J; Zhang R; Ma W; Shen C; Feng Y; Xia N; Xu D; Cai D; Li Y; Fang W
    Sci Rep; 2016 Oct; 6():35319. PubMed ID: 27731393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway.
    Lv Y; Qian Y; Fu L; Chen X; Zhong H; Wei X
    Eur J Pharmacol; 2015 Dec; 769():324-32. PubMed ID: 26607471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
    Min J; Wei C
    Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
    Hu T; Wei G; Xi M; Yan J; Wu X; Wang Y; Zhu Y; Wang C; Wen A
    Int J Mol Med; 2016 Jul; 38(1):83-94. PubMed ID: 27176815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxysafflor Yellow A Attenuates Neuron Damage by Suppressing the Lipopolysaccharide-Induced TLR4 Pathway in Activated Microglial Cells.
    Lv Y; Qian Y; Ou-Yang A; Fu L
    Cell Mol Neurobiol; 2016 Nov; 36(8):1241-1256. PubMed ID: 26754542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
    Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
    Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of hydroxysafflor yellow A against acute kidney injury via the TLR4/NF-κB signaling pathway.
    Bai J; Zhao J; Cui D; Wang F; Song Y; Cheng L; Gao K; Wang J; Li L; Li S; Jia Y; Wen A
    Sci Rep; 2018 Jun; 8(1):9173. PubMed ID: 29907783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory action of hydroxysafflor yellow A on inflammatory signal transduction pathway related factors in rats with cerebral cortex ischemia].
    Chen TT; Du YJ; Liu XL; Zhu HB
    Yao Xue Xue Bao; 2008 Jun; 43(6):570-5. PubMed ID: 18822957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.
    Jiang S; Shi Z; Li C; Ma C; Bai X; Wang C
    Int J Clin Exp Pathol; 2014; 7(5):2595-608. PubMed ID: 24966974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxysafflor yellow A protects against ulcerative colitis via suppressing TLR4/NF-κB signaling pathway.
    Feng Z; Zhou P; Wu X; Zhang J; Zhang M
    Chem Biol Drug Des; 2022 Jun; 99(6):897-907. PubMed ID: 35319164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effect of safflower yellow injection against rat MIRI by TLR-NF-κB inflammatory pathway].
    Li LM; Fu JH; Guo H; Han X; Li L; Xin GJ; Zhao YW; Zhang Q; Zheng QS; Liu JX
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2566-2571. PubMed ID: 31359725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN; Zhou ZM; Chen P
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.
    Lu M; Tang F; Zhang J; Luan A; Mei M; Xu C; Zhang S; Wang H; Maslov LN
    Phytother Res; 2015 Apr; 29(4):599-606. PubMed ID: 25604645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
    Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
    Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant effects of hydroxysafflor yellow A and acetyl-11-keto-β-boswellic acid in combination on isoproterenol-induced myocardial injury in rats.
    Chen M; Wang M; Yang Q; Wang M; Wang Z; Zhu Y; Zhang Y; Wang C; Jia Y; Li Y; Wen A
    Int J Mol Med; 2016 Jun; 37(6):1501-10. PubMed ID: 27121241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. κ-Opioid receptor stimulation modulates TLR4/NF-κB signaling in the rat heart subjected to ischemia-reperfusion.
    Lin J; Wang H; Li J; Wang Q; Zhang S; Feng N; Fan R; Pei J
    Cytokine; 2013 Mar; 61(3):842-8. PubMed ID: 23402995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
    Jin M; Wang L; Wu Y; Zang BX; Tan L
    Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice.
    Sun CY; Pei CQ; Zang BX; Wang L; Jin M
    Phytother Res; 2010 Dec; 24(12):1788-95. PubMed ID: 20564507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginkgetin exerts anti-inflammatory effects on cerebral ischemia/reperfusion-induced injury in a rat model via the TLR4/NF-κB signaling pathway.
    Li Q; Ye T; Long T; Peng X
    Biosci Biotechnol Biochem; 2019 Apr; 83(4):675-683. PubMed ID: 30570395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil attenuates myocardial ischemia-reperfusion injury via regulation of the TLR4/NF-κB signaling pathway.
    Li T; Yu J; Chen R; Wu J; Fei J; Bo Q; Xue L; Li D
    Pharmazie; 2014 Nov; 69(11):850-5. PubMed ID: 25985583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.